Etikk i praksis. Nordic Journal of Applied Ethics (2021),
15(1),
1–4
http://dx.doi.org/10.5324/eip.v15i1.4036
Leder
Introduction
What
our hopes and fears tell us about our values
Allen Alvarez, Espen Dyrnes Stabell, May Thorseth
The global community has
overcome great challenges after
more than a year of battling the
COVID-19 pandemic. This first issue of
Etikk
i praksis – Nordic Journal of
Applied Ethics for the year 2021
comes out as
2.18 billion doses of COVID-19
vaccines have been administered around
the world
(Holder 2021). Averaging these doses
across the total world population
yields
an ideal distribution of 28 per 100
people vaccinated. However, the
reality is that
many populations in different
countries have not received any of
those doses
yet, while people in other countries
have the luxury to avoid certain
vaccines
because of concerns about adverse
reactions. Achieving herd immunity and
avoiding the emergence of
vaccine-resistant variants of COVID-19
require that
vaccines are distributed more widely,
if not equitably, among different
populations around the world and not
just in high income countries. Most
ethical global frameworks for vaccine
distribution highlight four values:
“…helping the neediest, reducing
health disparities, saving lives and
keeping
society functioning” (Jecker, et al.
2021). The dire global situation has
pushed many societies to take social
justice seriously because the risks of
not
doing so can seriously affect even
those countries who can afford the
cost of
providing vaccines to all of their
citizens.
Our hope for ending the
global spread of COVID-19 points
out how important it is to keep our
communities safe from the harms of
this
terrible pandemic. That same hope also
makes clear that global justice and
equitable distribution of life-saving
resources, like vaccines, are not only
important for their own sake but also
because equitable distribution may be
more effective in protecting us all.
Indeed, delaying access to vaccines in
other
countries could result in the spread
of new variants that can pose risks
even
to fully vaccinated populations, no
matter the amount of vaccines that
rich
countries have.
Our fear of facing more
years under pandemic infection
control restrictions helps us
recognize the importance of enjoying
freedom of
movement, the value of social
interaction and having fewer
restrictions in our
lives as much as possible. These
challenging times give everyone
opportunity to
think about what should matter most
and how we can engage each other in
thinking hard about our collective
values. This engagement – using the
methods
and theories in applied ethics to
enable well-reasoned decisions about
what
should matter most in times of crisis
– is one of the important objectives
of Etikk
i Praksis – Nordic Journal of
Applied Ethics.
This open issue of the Nordic
Journal of Applied
Ethics consists of four papers
that discuss topics covering fetal
diagnostics ethics, value conflicts in
the use of artificial intelligence,
abortion and population ethics.
The first article in this
issue by Nora Levold, Marit
Svingen, & Ingrid Bruholt is
entitled Fosterdiagnostikk mellom
medisin
og etikk: Implementering av
NIPT–testen i et urolig
politikkområde (Fetal
diagnostics between medicine and
ethics: Implementation of non-invasive
prenatal testing in a turbulent policy
area) and examines how the decision to
implement non-invasive prenatal
testing (NIPT) in the Norwegian Fetal
Diagnostic System was reached through
a professional policy process between
2012 and 2017. The authors present a
careful convergence that took place
between the traditionally opposing
(and mutually exclusive) ways to
understand
and frame fetal diagnostics in Norway.
They refer to those opposing
approaches
as a ‘treatment frame’ and a ‘sorting
frame’. This convergence was possible
because the process was kept within
the bureaucracies of the Norwegian
Centre
for Health Services Research, the
Norwegian Directorate of Health, the
Norwegian
Biotechnology Advisory Board and the
Ministry of Health and Care Services.
These different agencies were willing
to collaborate to include knowledge
and
values from both frames in their
recommendations. The authors also
present the
fragility of this convergence, because
fetal diagnostics policy remains
controversial in Norwegian politics.
They recount the collapse of the
convergence during the three weeks of
May 2020 when the Norwegian Progress
Party suddenly entered a
“biotechnology settlement” with the
Labour Party and the
Socialist Left Party after exiting the
conservative Government coalition. The
authors acknowledge the almost
unsolvable dilemmas these framings
both produce
and represent.
The second article by
Thomas Søbirk Petersen – “Ethical
guidelines for the use of artificial
intelligence and value conflict
challenges” – critically examines the
value conflicts that arise in ethical
guidance of the use of artificial
intelligence. Guidelines for ethical
analysis
of AI use are indeed useful, but their
utility can be undermined by the
conflicting
values they aspire to enable. Petersen
aims to show the need for
distinguishing
between three kinds of conflict that
can exist for ethical guidelines and
discusses different approaches to
handling internal and external values
conflicts. The author presents three
strategies to resolve genuine value
conflict: (1) accepting the existence
of irresolvable conflict, (2) ranking
(prioritization) of values, and (3)
value monism. Of these three, the
author defends
the view that irresolvable conflicts
should be accepted. While
acknowledging
the theoretical advantage of adopting
the ranking view and value monism,
real-life decision-making in AI
guidance requires accepting
irresolvable value
conflicts to solve genuine conflicts
among values in ethical guidelines in.
The third article by
Silje Langseth Dahl, Rebekka Hylland
Vaksdal, Mathias Barra, Espen Gamlund
and Carl Tollef Solberg is an English
translation of a previously published
Norwegian article on abortion and
multifetal pregnancy reduction. This
translation moves the controversial
discussion beyond the Norwegian public
sphere to include a wider audience and
invite broader reflection on the
issue. Multifetal pregnancy reduction
(MFPR) continues
to be a subject of fierce debate in
Norway. The intensity of this debate
reached a high point when the
Legislation Department delivered its
interpretative
statement, Section 2 - Interpretation
of the Abortion Act in 2016, in
response
to a request from the Ministry of
Health (2014) that the Legislation
Department
consider whether the Abortion Act
allows for MFPR of healthy fetuses in
multiple pregnancies. The Legislation
Department concluded that the current
abortion legislation (as of 2016)
allows for MFPR subject to the
constraints
that the law otherwise stipulates. The
debate has not subsided and was
further
intensified during autumn 2018 in
connection with the Norwegian
Christian
Democratic "crossroads" policy and
signals from the Conservatives to
consider removing section 2.3c and to
prohibit MFPR. Many of the arguments
in
the MFPR debate appear similar to
arguments put forward in the general
abortion
debate, and an analysis to ascertain
what distinguishes MFPR from other
abortions has yet to be conducted. The
authors invite readers to examine
whether there is a moral distinction
between abortion and MFPR of healthy
fetuses. They present typical
arguments emerging in the debate in
Norway and illustrate
them with scholarly articles from the
literature. After presenting the most
important arguments against MFPR – the
harm argument, the slippery-slope
argument, the intention argument, the
grief argument, the long-term
psychological effects for the woman
argument and the sorting argument –
they concluded
that these arguments did not succeed
in demonstrating morally relevant
differences between MFPR of healthy
fetuses and other abortions. Hence,
the
authors maintain the view that there
is no morally relevant difference
between
the two and that the same conditions
for allowing MFPR should follow as for
other
abortions.
The fourth article by Mat
Rozas examines a dilemma in
reproductive and population ethics
that can illuminate broader questions
in value
theory and normative ethics. Rozas
reminds readers that most people have
conflicting intuitions concerning
whether the interests of non-existent
but
potential beings can outweigh the
interests of existing beings. Those
merely
potential (non-existent) beings are
expected to have overall net-good or
overall net-bad lives. The author
claims that the standard approach to
this
issue is not correct. Instead, Rozas
suggests that we approach the issue
through the distinction between
Symmetrical and Asymmetrical Views
about the
relative importance of positive and
negative value and the claim that
Asymmetrical Views give the most
intuitively satisfactory solution to
the
dilemma examined in the article. Rozas
notes that most authors hold the
standard interpretation of what
explains our asymmetrical attitudes
toward
having the Happy Child and not having
the Wretched Child, but he suggests
the
asymmetry between positive and
negative value as an alternative
account. Rozas
argues that readers should consider
negative value more important than
positive
value. While asymmetric views consider
suffering as something negative, they
need not consider happiness as
something positive. Lives where
suffering
prevails are net negative, but
asymmetric views need not consider
lives where
happiness prevails as net positive.
When we compare (a) sacrificing one
life
and bringing another into existence
with (b) not doing any of these two
things,
we may think that sacrificing life (a)
is worse than not doing anything (b).
Those
who hold the so-called
Person-affecting asymmetric views will
claim that (a) is
worse, while Impersonal asymmetric
views will consider (a) and (b)
equivalent. Rozas
provides a different explanation for
the asymmetric view regarding
attitudes
toward bringing happy children into
existence and bringing wretched
children
into existence that is different from
the more widely held person-affecting
views. His theoretical examination of
these intuitions can help sharpen our
understanding of the implications of
trade-offs we need to make in creating
policies that affect populations,
including those that affect future
generations.
Finally,
our
book review for this issue by
Alexander Myklebust explores ideas
related to
how
Responsible Research and Innovation
(RRI) can be
practised and assessed in the future.
RRI scholars will have to figure out
whether they want to hold onto a
science-oriented RRI or fully embrace
the
systems approach. Myklebust commends
the way in which several of the
authors of
the reviewed volume have broadened the
scope of RRI towards a genuinely
systems-oriented approach. Myklebust
considers approaches that are more in
line
with a linear method to be suitable
for contexts where it is possible to
envisage a more or less step-wise
innovation trajectory that can be
assessed
either at an early stage or throughout
the process of developing innovative
technology. It might be true today
that many, if not most, innovations
are more
or less systemic in nature. But in
cases where innovation processes are
driven
by research and development, there
will still be a need for methods that
focus
on stakeholder involvement and
foresight geared towards tackling
fundamental
problems.
The
editors of Etikk i praksis
invite readers to continue reflecting on
ways
we can resolve the decision dilemmas we
face in these challenging times.
Identifying what should matter most in
these decisions is a crucial step.
Reflecting on choices that support the
most reasonable solutions and the
trade-off
of values we make is another.
References
Holder, J.
(2001). Tracking Coronavirus
Vaccinations Around the World. The
New York Times. Available at:
https://www.nytimes.com
/interactive/2021/world/covid-vaccinations-tracker.html
Date accessed: June 8, 2021.
Jecker, N. S.,
Wightman, A. G., & Diekema, D.
S. (2021). Vaccine ethics: an
ethical framework for global
distribution of COVID-19 vaccines.
Journal of Medical Ethics, 47(5),
308-317. CrossRef